An Introduction to Mirtrons - The Tiny RNA Molecules That Play a Role in Cancer

Medical News: Imagine tiny warriors inside your body, so small you can’t see them, fighting a big enemy like cancer. These warriors are called mirtrons, a special kind of RNA molecule that researchers are just starting to understand. Unlike their more famous cousins, microRNAs (or miRNAs for short), mirtrons have a unique way of being ‘born’ and might hold the key to new ways to detect and treat cancer. A team of scientists from the National Kaohsiung University of Science and Technology in Taiwan and Texas Tech University in the United States has been digging into how these little heroes work, and their findings could change the future of medicine.


An Introduction to Mirtrons - The Tiny RNA Molecules That Play a Role in Cancer

RNA, if you’re wondering, is like a helper in your cells, carrying instructions from your DNA to make everything in your body run smoothly. Most miRNAs follow a standard path to get made, but mirtrons take a shortcut through a process called splicing. Picture it like skipping a step in a recipe - mirtrons don’t need the usual tools other RNAs rely on, which makes them special. This Medical News report shows that because of this difference, mirtrons can pop up in places and ways that other RNAs can’t, especially when it comes to cancer.
 
The Birth of a Mirtron: A Clever Shortcut
To get why mirtrons matter, let’s break it down simply. Regular miRNAs are made in a factory-like process inside the cell’s nucleus. A ‘machine’ called Drosha chops them into shape before they’re sent out to do their job - telling genes to turn on or off. But mirtrons? They skip that Drosha step entirely. Instead, they’re carved out of introns - bits of genetic material that get snipped away when a cell is making proteins. It’s like finding a diamond in the rough: these introns, usually thrown out as waste, turn into mirtrons that can control how cells behave.
 
The researchers, led by Yi-Ling Chen from National Kaohsiung University of Science and Technology and Kuan-Hui Ethan Chen from Texas Tech University, found that this splicing trick lets mirtrons play a unique role in the body. They studied 480 confirmed human mirtrons and discovered they come from introns of all sizes - some as tiny as 100 base pairs (think of base pairs as the building blocks of DNA), others stretching over 26,000 base pairs long. This variety shows how flexible mirtrons are, popping up in unexpected places to tackle jobs that other RNAs might miss.
 
Mirtrons and Cancer: A Double-Edged Sword
Now, here’s where it gets exciting - and a little tricky. Mirtrons aren’t just floating around doing nothing; they’re deeply involved in cancer. The study found that these tiny RNAs can act like switches, flipping genes on or off to either help cancer grow or stop it in its tracks. For example, in liver cancer, a mirtron called hsa-mir-1228 targets a gene called TP53, which normally acts like a brake on cancer cells. When this mirtron shuts TP53 down, cancer cells multiply unchecked.
 
Similarly, in ovarian cancer, hsa-mir-937-5p goes after a gene called FBXO16, letting cancer spread faster by dodging the body’s natural defenses.
 
But it’s not all bad news. Some mirtrons are like superheroes fighting for good. Take hsa-mir-1292, which takes aim at a troublemaker gene called DEK in stomach cancer. By shutting DEK down, this mirtron slows cancer growth, giving the body a fighting chance.
 
The researchers also noticed that mirtrons don’t act the same in every cancer - hsa-mir-1229-3p is a villain in breast and pancreatic cancers, pushing them to grow, but in colorectal cancer, hsa-mir-1226-3p takes a different stance, sometimes even shrinking tumors. It’s like mirtrons are playing a game of chess, with different moves depending on the board they’re on.
 
Rewiring Cancer’s Energy Supply
Cancer cells are greedy - they need tons of energy to grow and spread. The study uncovered how mirtrons help them get it. One big trick cancer uses is called the Warburg effect, where it switches to a fast but inefficient way of burning sugar for fuel, even when oxygen is around. In breast cancer, hsa-mir-1229-3p messes with a gene called ZBTB1, which normally keeps this sugar-burning in check. When the mirtron steps in, cancer cells get a free pass to guzzle sugar, growing stronger.
 
Then there’s something called one-carbon metabolism - a fancy term for how cancer cells make building blocks for DNA and other essentials. The mirtron hsa-mir-6778-5p boosts this process in stomach cancer by targeting a gene called YWHAE, which frees up another gene, SHMT1, to keep cancer cells thriving. And in a mouse study, hsa-mir-1224-5p was caught encouraging fat production in the liver by shutting down a gatekeeper called AMPK-α1. Scientists think this could happen near tumors too, feeding cancer cells extra energy from nearby fat cells. It’s like mirtrons are handing cancer a cheat code to keep running.
 
Spreading the Trouble: Migration and Metastasis
Cancer doesn’t just sit still - it spreads, and mirtrons help it move. In colorectal cancer, hsa-mir-1226-5p pushes cells to migrate and transform through a process called EMT (epithelial-to-mesenchymal transition), making them slippery and hard to catch. In aggressive triple-negative breast cancer, hsa-mir-877-5p knocks out a protector gene called TIMP3, letting cancer cells break free and invade other parts of the body. But here’s the twist - this same mirtron can slow cancer down in prostate and bladder cancers, showing how tricky and context-specific these little RNAs can be.
 
Even wilder, some mirtrons hitch a ride in tiny packages called exosomes, traveling through the blood to spark trouble far away. In small cell lung cancer, hsa-mir-1228-5p rides exosomes to target DUSP22, boosting migration. It’s like cancer’s sending secret agents to set up new bases.
 
Dodging the Cure: Therapy Resistance
Cancer’s sneakiness doesn’t stop there - it can dodge treatments, and mirtrons are part of the plot. In breast cancer, treatments like tamoxifen and fulvestrant aim to block estrogen signals, but mirtrons like hsa-mir-1226 and hsa-mir-1228 make cells resistant, letting cancer shrug off the drugs. Another mirtron, hsa-mir-1233-3p, tweaks a pathway called PI3K/Akt/mTOR, helping breast cancer ignore tamoxifen and even a drug called Palbociclib. In liver cancer, hsa-mir-1228-3p rides exosomes to shield cells from sorafenib, a common treatment, by targeting PLAC8 and firing up survival signals.
 
This resistance is a big deal - it’s why some cancers come back stronger. The researchers think targeting these mirtrons could flip the script, making treatments work better and longer.
 
Hiding from the Immune System
Cancer also hides from the body’s immune police, and mirtrons help it stay undercover. In colorectal cancer, hsa-mir-1226-5p tricks immune cells called macrophages into becoming cancer-friendly, pumping out a chemical (TGF-β) that calms the immune attack. In ovarian cancer, hsa-mir-1225-5p does a similar job by targeting TLR2, letting cancer dodge detection. But not all mirtrons are villains - hsa-mir-7109 fights back by hitting an immune checkpoint called siglec-15, waking up the immune system to attack tumors. It’s a battlefield, and mirtrons are picking sides.
 
A New Hope for Cancer Care
So, what does all this mean for regular folks? The researchers from National Kaohsiung University of Science and Technology and Texas Tech University say mirtrons could be game-changers. Because they’re tied to specific cancers and processes, they might work as warning signs – biomarkers - to catch cancer early. Imagine a simple blood test spotting these RNAs before tumors get big. Plus, since mirtrons skip the usual RNA-making steps, scientists could design drugs to block their bad effects or boost their good ones, offering new ways to fight cancer tailored to each person.
 
The team’s work shows that of the 480 known human mirtrons, many are still mysteries waiting to be solved. Their ability to dodge destruction in cancer cells - unlike in healthy ones - hints at a secret weapon cancer uses, and cracking that could lead to breakthroughs. With better tools like RNA profiling, the future looks bright for turning mirtrons into allies against cancer.
 
Wrapping It Up: A Tiny Molecule with Big Promise
This deep dive into mirtrons reveals a world of tiny RNAs with massive potential. They’re not just bystanders—they’re active players in cancer’s story, helping it grow, spread, and resist treatment, but also offering ways to fight back. Their unique birth through splicing, their knack for dodging degradation, and their varied roles across cancers make them a hot topic for science. The researchers believe that as we learn more, mirtrons could lead to sharper diagnostics and smarter therapies, giving doctors new tools to save lives. It’s a long road, but these small warriors might just rewrite how we tackle cancer, one patient at a time.
 
The study findings were published in the peer-reviewed journal: Onco.
https://www.mdpi.com/2673-7523/5/1/7
 
For the latest Cancer News, keep on logging to Thailand Medical News.
 
Read Also:
https://www.thailandmedical.news/news/coronavirus-defective-genomes-influence-immunity-and-viral-spread
 
https://www.thailandmedical.news/news/discovery-of-viral-hormones-and-virally-encoded-growth-factors-opens-new-dimensions-in-virology-endocrinology-and-medicine
 
https://www.thailandmedical.news/news/breaking-viral-peptide-fragments-from-sars-cov-2-can-reassemble-into-proinflammatory-supramolecular-complexes
 
https://www.thailandmedical.news/news/breaking-medical-news-discovery-of-hidden-viral-proteins-in-ssrna-viruses-opens-a-new-dimension-in-virology-and-is-relevant-for-sars-cov-2
 
https://www.thailandmedical.news/news/breaking-covid-19-news-australian-scientists-discover-a-microrna-called-cov2-mir-o8-that-is-encoded-by-sars-cov-2-and-is-possibly-pathogenetic
 
https://www.thailandmedical.news/news/must-read-study-proposes-role-of-sars-cov-2-spike-protein,-stem-cells-and-retrotransposons-in-long-covid-syndrome
 
https://www.thailandmedical.news/news/there-is-no-such-thing-as-long-covid-sars-cov-2-exposure-causes-persistent-infections-along-with-continuous-presence-of-short-viral-rnas-svrnas
 
https://www.thailandmedical.news/news/latest-sars-cov-2-research-study-discovers-that-sars-cov-2-encoded-small-rnas-represses-host-expression-of-serinc5-for-viral-replication-
 
https://www.thailandmedical.news/news/breaking-covid-19-news-discovery-of-sars-cov-2-short-rnas-by-scientist-from-john-hopkins-is-a-big-gamechanger-in-terms-of-pathogenesis-and-long-covid
 
https://www.thailandmedical.news/news/breaking-long-covid-is-a-misnomer-the-conditions-are-being-caused-by-viral-persistence-and-viral-peptides-similar-to-retrotransposons-and-introns
 
https://www.thailandmedical.news/pages/thailand_doctors_listings